Philip L. Johnson's most recent trade in Jazz Pharmaceuticals plc was a trade of 1,149 Ordinary Shares done at an average price of $139.0 . Disclosure was reported to the exchange on March 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals plc | Philip L. Johnson | EVP & Chief Financial Officer | Sale or transfer of securities back to the company at price $ 138.95 per share. | 05 Mar 2025 | 1,149 | 50,060 (0%) | 0% | 139.0 | 159,654 | Ordinary Shares |
Jazz Pharmaceuticals plc | Philip L. Johnson | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 15,407 | 43,505 (0%) | 0% | 0 | Ordinary Shares | |
Jazz Pharmaceuticals plc | Philip L. Johnson | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 7,704 | 51,209 (0%) | 0% | 0 | Ordinary Shares | |
Jazz Pharmaceuticals plc | Philip L. Johnson | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 15,932 | 15,932 (0%) | 0% | 0 | Ordinary Shares | |
Jazz Pharmaceuticals plc | Philip L. Johnson | EVP & Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 119.65 per share. | 01 Mar 2024 | 12,000 | 27,932 (0%) | 0% | 119.7 | 1,435,800 | Ordinary Shares |